The Sackler dynasty’s ruthless marketing of painkillers has generated billions of dollars—and millions of addicts. The OxyContin Clan: The $14 Billion Newcomer to Forbes 2015 List of Richest U.S. Families OxyContin.
Purdue, 100% owned by the Sacklers, has generated estimated sales of more than $35 billion since releasing its time-released, supposedly addiction-proof version of the painkiller oxycodone back in 1995. Its annual revenues are about $3 billion, still mostly from OxyContin. The Sacklers also own separate drug companies that sell to Asia, Latin America, Canada and Europe, together generating similar total sales as Purdue’s operation in the United States.